Sign up for free insights newsletter
45

ONO PHARMACEUTICAL CO.,LTD.

4528Tokyo Stock Exchange

Need professional-grade analysis? Visit stockanalysis.com

¥2,312.50
+0.35%
End of day
Market Cap

$1.07T

P/E Ratio

N/A

Employees

N/A

Dividend Yield

N/A

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino-0.43-3.060.153.182.471.27
Calmar-3.92-5.930.213.762.950.98
Sharpe-0.28-2.610.112.191.650.79
Omega0.940.491.041.371.291.13
Martin-6.05-10.620.399.407.743.35
Ulcer1.255.957.535.535.285.62

ONO PHARMACEUTICAL CO.,LTD. (4528) Price Performance

ONO PHARMACEUTICAL CO.,LTD. (4528) trades on Tokyo Stock Exchange in JPY. The company is classified in the Healthcare sector under the Drug Manufacturers - General industry. The stock currently trades at JPY2312.50, up 0.35% from the previous close.

Over the past year, 4528 has traded between a low of JPY1492.00 and a high of JPY2674.50. The stock has gained 40.7% over this period. It is currently 13.5% below its 52-week high.

ONO PHARMACEUTICAL CO.,LTD. has a market capitalization of $1.07T.

About ONO PHARMACEUTICAL CO.,LTD.

ONO PHARMACEUTICAL CO.,LTD. (4528) is a leading healthcare company based in Japan that specializes in the research, development, and commercialization of innovative pharmaceutical products. The company's primary focus is on the development of novel drugs for the treatment of a wide range of medical conditions, with a strong emphasis on oncology, immunology, and neurology. ONO PHARMACEUTICAL CO.,LTD. generates a significant portion of its revenue from product sales in Japan and other Asian markets, as well as through royalties from its collaborations and licensing agreements.

Compare ONO PHARMACEUTICAL CO.,LTD.

Side-by-side comparison against top Healthcare peers.

Company Info

Exchange
Tokyo Stock Exchange
Currency
JPY
Country
Japan

Financial Metrics

Revenue (TTM)
N/A
EBITDA
N/A
Profit Margin
N/A
EPS (TTM)
N/A
Book Value
N/A

Technical Indicators

52 Week High
¥2,674.50
52 Week Low
¥1,474.00
50 Day MA
¥2,471.39
200 Day MA
¥2,065.16
Beta
N/A

Valuation

Trailing P/E
N/A
Forward P/E
N/A
Price/Sales
N/A
Price/Book
N/A
Enterprise Value
$1.07T